Form 4 holding
Chief Scientific Officer, Director
ORAMED PHARMACEUTICALS INC.
- Security class
- Common Stock
- Shares / value
- 1,133,138
- Estimated value
- $3,229,443
- Report date
- 30 Mar 2026
- Price
- $2.85
- Ownership
- Direct
Miriam Kidron - Chief Scientific Officer, Director at ORAMED PHARMACEUTICALS INC.
Issuer-level insider activity
- Role
- Chief Scientific Officer, Director
- Issuer ticker
- ORMP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Miriam Kidron since 05 Aug 2025
Reported holdings for Miriam Kidron in ORAMED PHARMACEUTICALS INC.
Form 4 holding
Chief Scientific Officer, Director
ORAMED PHARMACEUTICALS INC.
- Security class
- Performance Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 22 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Miriam Kidron in ORAMED PHARMACEUTICALS INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.